Medtronic Announces Strategic Investment in Pi-Cardia to Accelerate Innovation for Complex TAVR

{
  "signal_id": "a78fc8b7-42b1-95e8-649f-0eafa13e96da",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-09-01T10:30:00+00:00",
  "company": {
    "name": "Medtronic",
    "domain": "medtronic.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/medtronic-announces-strategic-investment-in-pi-cardia-to-accelerate-innovation-for-complex-tavr-302865441.html",
    "title": "Medtronic Announces Strategic Investment in Pi-Cardia to Accelerate Innovation for Complex TAVR",
    "excerpt": "GALWAY, Ireland and REHOVOT, Israel , Sept. 1, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT ), a global leader in healthcare technology, and Pi-Cardia Ltd., a pioneer in leaflet modification technologies for structural heart disease, today announced a strategic investment by Medtronic in Pi-Cardia Ltd. With a focus on addressing the evolving needs of increasingly complex transcatheter aortic valve replacement (TAVR) patients and procedures, Medtronic secures an option for strengthening its structural heart portfolio through this strategic investment, supporting the next generation of innovation. Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction. The device provides physicians with a safe, easy-to-learn, reproducible approach to leaflet modification that can help preserve coronary access and enable future transcatheter valve procedures. In FDA-reviewed clinical studies, ShortCut™ demonstrated successful leaflet splitting in all pivotal trial patients and a favorable safety profile. \"As structural heart care evolves, we're investing in technologies that help physicians address today's challenges while preparing for tomorrow's opportunities,\" said Jorie Soskin, vice president and general manager of the Structural Heart business within Medtronic's...",
    "summary": "Medtronic has secured an option to acquire Pi-Cardia Ltd. for up to $210 million plus potential earn-out payments upon the achievement of predefined milestones.",
    "location": "Galway, Ireland",
    "planning": true,
    "image_url": "https://mmx.prnewswire.com/media/MS1979050/Pi-Cardia-ShortCut-Device.jpg?id=OA2921973&p=facebook",
    "confidence": 0.9,
    "published_at": "2026-09-01T10:30:00Z",
    "location_data": [
      {
        "city": "Galway",
        "state": "County Galway",
        "region": "Northern Europe",
        "country": "Ireland",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "The agreement also includes an option for Medtronic to acquire Pi-Cardia upon achievement of predefined milestones for an estimated upfront acquisition price of up to $210 million, subject to customary adjustments, plus additional potential earn-out payments post-acquisition that could meaningfully increase the total consideration.",
    "amount_normalized": 210000000,
    "related_company_name": "Pi-Cardia Ltd.",
    "related_company_domain": "pi-cardia.net"
  }
}

curl https://signals.autobound.ai/v1/signals/a78fc8b7-42b1-95e8-649f-0eafa13e96da \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"medtronic.com","limit":20}'